Kristen represents life sciences companies on their most significant transactions, from strategic license and collaboration transactions to complex supply chain arrangements. She has a deep technical understanding of the life sciences industry, and has negotiated agreements in respect of cutting-edge technologies including gene editing and cell therapies.
Kristen is also nationally recognized for her work counseling life sciences and other companies that engage in US Government-funded research and development. In 2020, Kristen represented several of the most high-profile vaccine manufacturers in their agreements to develop and deliver billions of doses of COVID-19 vaccines to the United States.
Kristen has a degree in electrical engineering and is a registered patent attorney.